[
  {
    "ts": null,
    "headline": "CVS Health (CVS) Dips More Than Broader Market: What You Should Know",
    "summary": "CVS Health (CVS) closed the most recent trading day at $61.96, moving 2.12% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=70766e75f61b4a55d5ec6f7f98e544cd01051d78c0e938de5e655b2e88028326",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752875104,
      "headline": "CVS Health (CVS) Dips More Than Broader Market: What You Should Know",
      "id": 136012054,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) closed the most recent trading day at $61.96, moving 2.12% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=70766e75f61b4a55d5ec6f7f98e544cd01051d78c0e938de5e655b2e88028326"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock underperforms Friday when compared to competitors",
    "summary": "CVS Health Corp. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=30d3b057444012f44695ada630991311d70e18cb49b318b300ef2f621324183e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752856860,
      "headline": "CVS Health Corp. stock underperforms Friday when compared to competitors",
      "id": 136050547,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=30d3b057444012f44695ada630991311d70e18cb49b318b300ef2f621324183e"
    }
  },
  {
    "ts": null,
    "headline": "Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings",
    "summary": "MOH's Q2 revenues are set to rise nearly 10%, but rising costs cloud its profit outlook.",
    "url": "https://finnhub.io/api/news?id=7e425f1647e4d45445e854a79d68d35beff6b6d5f5f4a1108b9ebe3308173ee0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752854580,
      "headline": "Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings",
      "id": 136007914,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "MOH's Q2 revenues are set to rise nearly 10%, but rising costs cloud its profit outlook.",
      "url": "https://finnhub.io/api/news?id=7e425f1647e4d45445e854a79d68d35beff6b6d5f5f4a1108b9ebe3308173ee0"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?",
    "summary": "DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.",
    "url": "https://finnhub.io/api/news?id=659db87a18308be51bdb1c4691bb5b7140ba7805ceb4655739300e20031fffac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752852360,
      "headline": "Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?",
      "id": 136007923,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.",
      "url": "https://finnhub.io/api/news?id=659db87a18308be51bdb1c4691bb5b7140ba7805ceb4655739300e20031fffac"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Pressured by Weakness in Netflix and Health Insurers",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) today down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. September E-mini S&P futures (ESU25 ) are down -0.14%, and September E-mini Nasdaq futures (NQU25...",
    "url": "https://finnhub.io/api/news?id=2cf09540c35b5732b53f91482e528abd72f8dee8d226a52eb0442bbbda6eb1d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752852268,
      "headline": "Stocks Pressured by Weakness in Netflix and Health Insurers",
      "id": 136005384,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The S&P 500 Index ($SPX ) (SPY ) today down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. September E-mini S&P futures (ESU25 ) are down -0.14%, and September E-mini Nasdaq futures (NQU25...",
      "url": "https://finnhub.io/api/news?id=2cf09540c35b5732b53f91482e528abd72f8dee8d226a52eb0442bbbda6eb1d5"
    }
  },
  {
    "ts": null,
    "headline": "Humana stock falls after losing Medicare bonus payment lawsuit",
    "summary": "Investing.com -- Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted other health insurers, with CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) shares declining 2%.",
    "url": "https://finnhub.io/api/news?id=4c4d3f64c1790ace983faf89620a34ff119721edb736e1739832f96b853d3bdb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752849977,
      "headline": "Humana stock falls after losing Medicare bonus payment lawsuit",
      "id": 136005502,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Investing.com -- Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted other health insurers, with CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) shares declining 2%.",
      "url": "https://finnhub.io/api/news?id=4c4d3f64c1790ace983faf89620a34ff119721edb736e1739832f96b853d3bdb"
    }
  },
  {
    "ts": null,
    "headline": "Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?",
    "summary": "The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
    "url": "https://finnhub.io/api/news?id=7fa62144a2eb71891d01e9fd4a74107188038c8744bc42c5605ef0236af24ec4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752845403,
      "headline": "Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?",
      "id": 136005918,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
      "url": "https://finnhub.io/api/news?id=7fa62144a2eb71891d01e9fd4a74107188038c8744bc42c5605ef0236af24ec4"
    }
  },
  {
    "ts": null,
    "headline": "U.S. health insurers seek largest jump in Obamacare premiums since 2018, study shows",
    "summary": "(Reuters) -U.S. insurers are requesting the biggest premium increases for Obamacare plans since 2018, according to an analysis by health-research firm KFF, prompted by the looming expiry of premium tax credits and potential tariffs on medical goods.  Insurers are proposing a median premium increase of 15% for 2026, KFF said, citing data from rate filings of 105 insurers across 19 states.  In recent years, premiums in the plans have been relatively flat or grown only modestly.",
    "url": "https://finnhub.io/api/news?id=69543de0a4867b87521fa617e5e7f013d574fd0aca3129d00e3829c8b7b07d4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752844573,
      "headline": "U.S. health insurers seek largest jump in Obamacare premiums since 2018, study shows",
      "id": 136005503,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "(Reuters) -U.S. insurers are requesting the biggest premium increases for Obamacare plans since 2018, according to an analysis by health-research firm KFF, prompted by the looming expiry of premium tax credits and potential tariffs on medical goods.  Insurers are proposing a median premium increase of 15% for 2026, KFF said, citing data from rate filings of 105 insurers across 19 states.  In recent years, premiums in the plans have been relatively flat or grown only modestly.",
      "url": "https://finnhub.io/api/news?id=69543de0a4867b87521fa617e5e7f013d574fd0aca3129d00e3829c8b7b07d4c"
    }
  },
  {
    "ts": null,
    "headline": "TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus",
    "summary": "Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.",
    "url": "https://finnhub.io/api/news?id=67bc7bec0748659333bc380cbcecb56dd9dc0d4884eb389b985c4d1c9302a45d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752842100,
      "headline": "TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus",
      "id": 136005746,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.",
      "url": "https://finnhub.io/api/news?id=67bc7bec0748659333bc380cbcecb56dd9dc0d4884eb389b985c4d1c9302a45d"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?",
    "summary": "CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.",
    "url": "https://finnhub.io/api/news?id=0ff9aabaa3c71ded3d8f9a6076da69f81ca2abd2562c57e80664cbad8fd834f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752842040,
      "headline": "CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?",
      "id": 136005505,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.",
      "url": "https://finnhub.io/api/news?id=0ff9aabaa3c71ded3d8f9a6076da69f81ca2abd2562c57e80664cbad8fd834f7"
    }
  }
]